Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001798385 | SCV000319755 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-01-20 | criteria provided, single submitter | clinical testing | The p.P1390T variant (also known as c.4168C>A), located in coding exon 25 of the NOTCH1 gene, results from a C to A substitution at nucleotide position 4168. The proline at codon 1390 is replaced by threonine, an amino acid with highly similar properties. This variant was first described in two patients with bicuspid aortic valve and thoracic aortic aneurysm (McKellar et al. J Thorac Cardiovasc Surg. 2007;134(2):290-6; Girdauskas E. et al. Eur J Cardiothorac Surg. 2017;Apr:156-162). In addition, this variant has been reported in a newborn male with tetralogy of Fallot, pulmonic stenosis, and cryptorchidism (Ceyhan-Birsoy O et al. Am. J. Hum. Genet., 2019 Jan;104:76-93). This variant has also been seen in a whole genome sequencing cohort, but cardiovascular history was not provided (Bodian DL et al. PLoS ONE. 2014;9(4):e94554). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Invitae | RCV000525275 | SCV000659441 | likely benign | Adams-Oliver syndrome 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000660162 | SCV000782156 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000121685 | SCV000966705 | uncertain significance | not specified | 2018-02-14 | criteria provided, single submitter | clinical testing | The p.Pro1390Thr (NM_017617.3 c.4168C>A) variant in NOTCH1 has been reported in 2 individuals with bicuspid aortic valve disease (McKellar 2007 and Girdauskas 2 017), and has been identified in 0.1% (126/117,504) of European chromosomes by t he Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs191645600). It has also been reported in ClinVar (Variation ID#134935). Comput ational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Pro1390Thr variant is uncertain. |
Clinical Molecular Genetics Laboratory, |
RCV001836733 | SCV001021975 | uncertain significance | Heart, malformation of | 2019-12-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001562831 | SCV001785661 | likely benign | not provided | 2020-09-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30609409, 28387797, 27059385, 23102684, 20497191, 17662764, 24728327) |
CHEO Genetics Diagnostic Laboratory, |
RCV001798385 | SCV002043520 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-01-17 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV002055371 | SCV002495877 | uncertain significance | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-03-30 | criteria provided, single submitter | clinical testing | NOTCH1 NM_017617.4 exon 25 p.Pro1390Thr (c.4168C>A): This variant has been reported in the literature in two individuals with bicuspid aortic valve and aortic dilation, as well as in one neonate with TOF, pulmonic stenosis, and cryptorchidism (McKellar 2007 PMID:17662764, Girdauskas 2017 PMID:28387797, Ceyhan-Birsoy 2019 PMID:30609409). However, this variant is also present in 0.1% (72/68038) of European alleles in the Genome Aggregation Database, including one homozygote (https://gnomad.broadinstitute.org/variant/9-136505728-G-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:134935). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV001562831 | SCV004162025 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | NOTCH1: BS1 |
ARUP Laboratories, |
RCV001562831 | SCV004563204 | likely benign | not provided | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003945096 | SCV004764315 | likely benign | NOTCH1-related condition | 2021-09-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
ITMI | RCV000121685 | SCV000085883 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genome Diagnostics Laboratory, |
RCV000121685 | SCV001808508 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001562831 | SCV001931656 | likely benign | not provided | no assertion criteria provided | clinical testing |